Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-01-25 @ 3:39 AM
Study NCT ID:
NCT01458067
Status:
COMPLETED
Last Update Posted:
2018-07-24
First Post:
2011-10-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11-10
Start Date Type:
ACTUAL
Primary Completion Date:
2015-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02-25
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-13
First Submit QC Date:
None
Study First Post Date:
2011-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-20
Last Update Post Date:
2018-07-24
Last Update Post Date Type:
ACTUAL